Colowick Alan
SEC insider (Form 3/4/5 filer). CIK 0001316163. Director at ALUMIS INC. (ALMS) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Apr 2, 2025. Located in WALTHAM, MA.
Companies Colowick Alan has filed insider reports for
- ALUMIS INC. (ALMS): Director
- Maze Therapeutics, Inc. (MAZE): Director
Colowick Alan
CIK: 0001316163
Transaction Breakdown
Open Market Buys (P)2 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
